496 related articles for article (PubMed ID: 33407005)
1. Critical role of neutralizing antibody for SARS-CoV-2 reinfection and transmission.
Kim YI; Kim SM; Park SJ; Kim EH; Yu KM; Chang JH; Kim EJ; Casel MAB; Rollon R; Jang SG; Um J; Song MS; Jeong HW; Kim EG; Kim Y; Kim SY; Park JS; Park MS; Kwon GY; Yeo SG; Lee SA; Choi YJ; Jung JU; Choi YK
Emerg Microbes Infect; 2021 Dec; 10(1):152-160. PubMed ID: 33407005
[TBL] [Abstract][Full Text] [Related]
2. Transmission and Protection against Reinfection in the Ferret Model with the SARS-CoV-2 USA-WA1/2020 Reference Isolate.
Patel DR; Field CJ; Septer KM; Sim DG; Jones MJ; Heinly TA; Vanderford TH; McGraw EA; Sutton TC
J Virol; 2021 Jun; 95(13):e0223220. PubMed ID: 33827954
[TBL] [Abstract][Full Text] [Related]
3. The serological IgG and neutralizing antibody of SARS-CoV-2 omicron variant reinfection in Jiangsu Province, China.
Chu J; Dai Q; Dong C; Kong X; Tian H; Li C; Peng J; Xu K; Ju H; Bao C; Hu J; Zhu L
Front Public Health; 2024; 12():1364048. PubMed ID: 38873290
[TBL] [Abstract][Full Text] [Related]
4. Prior aerosol infection with lineage A SARS-CoV-2 variant protects hamsters from disease, but not reinfection with B.1.351 SARS-CoV-2 variant.
Yinda CK; Port JR; Bushmaker T; Fischer RJ; Schulz JE; Holbrook MG; Shaia C; de Wit E; van Doremalen N; Munster VJ
Emerg Microbes Infect; 2021 Dec; 10(1):1284-1292. PubMed ID: 34120579
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 infection induces protective immunity and limits transmission in Syrian hamsters.
Selvaraj P; Lien CZ; Liu S; Stauft CB; Nunez IA; Hernandez M; Nimako E; Ortega MA; Starost MF; Dennis JU; Wang TT
Life Sci Alliance; 2021 Apr; 4(4):. PubMed ID: 33574037
[TBL] [Abstract][Full Text] [Related]
6. Age-dependent pathogenic characteristics of SARS-CoV-2 infection in ferrets.
Kim YI; Yu KM; Koh JY; Kim EH; Kim SM; Kim EJ; Casel MAB; Rollon R; Jang SG; Song MS; Park SJ; Jeong HW; Kim EG; Lee OJ; Kim YD; Choi Y; Lee SA; Choi YJ; Park SH; Jung JU; Choi YK
Nat Commun; 2022 Jan; 13(1):21. PubMed ID: 35013229
[TBL] [Abstract][Full Text] [Related]
7. Recovery scenario and immunity in COVID-19 disease: A new strategy to predict the potential of reinfection.
Khoshkam Z; Aftabi Y; Stenvinkel P; Paige Lawrence B; Rezaei MH; Ichihara G; Fereidouni S
J Adv Res; 2021 Jul; 31():49-60. PubMed ID: 33520309
[TBL] [Abstract][Full Text] [Related]
8. Mild SARS-CoV-2 Illness Is Not Associated with Reinfections and Provides Persistent Spike, Nucleocapsid, and Virus-Neutralizing Antibodies.
Schuler CF; Gherasim C; O'Shea K; Manthei DM; Chen J; Zettel C; Troost JP; Kennedy AA; Tai AW; Giacherio DA; Valdez R; Baldwin JL; Baker JR
Microbiol Spectr; 2021 Oct; 9(2):e0008721. PubMed ID: 34468184
[TBL] [Abstract][Full Text] [Related]
9. Protective immunity after recovery from SARS-CoV-2 infection.
Kojima N; Klausner JD
Lancet Infect Dis; 2022 Jan; 22(1):12-14. PubMed ID: 34762853
[No Abstract] [Full Text] [Related]
10. Experimental re-infected cats do not transmit SARS-CoV-2.
Gaudreault NN; Carossino M; Morozov I; Trujillo JD; Meekins DA; Madden DW; Cool K; Artiaga BL; McDowell C; Bold D; Balaraman V; Kwon T; Ma W; Henningson J; Wilson DW; Wilson WC; Balasuriya UBR; García-Sastre A; Richt JA
Emerg Microbes Infect; 2021 Dec; 10(1):638-650. PubMed ID: 33704016
[TBL] [Abstract][Full Text] [Related]
11. Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection.
Cromer D; Juno JA; Khoury D; Reynaldi A; Wheatley AK; Kent SJ; Davenport MP
Nat Rev Immunol; 2021 Jun; 21(6):395-404. PubMed ID: 33927374
[TBL] [Abstract][Full Text] [Related]
12. Comparative Assessment of Severe Acute Respiratory Syndrome Coronavirus 2 Variants in the Ferret Model.
Pulit-Penaloza JA; Belser JA; Sun X; Pappas C; Brock N; Kieran TJ; Ritter JM; Seixas JN; Jones J; Basu Thakur P; Pusch E; Wang L; Tumpey TM; Wentworth DE; Zhou B; Maines TR
mBio; 2022 Oct; 13(5):e0242122. PubMed ID: 36135377
[TBL] [Abstract][Full Text] [Related]
13. Correlates of protection from SARS-CoV-2 infection.
Krammer F
Lancet; 2021 Apr; 397(10283):1421-1423. PubMed ID: 33844964
[No Abstract] [Full Text] [Related]
14. Viral Shedding among Re-Positive Severe Acute Respiratory Syndrome Coronavirus-2 Positive Individuals in Republic of Korea.
Kim JM; Ryu B; Choe YJ; Jo HJ; Lee H; Kim HM; Lee NJ; Rhee JE; Chung YS; Han MG; Kim EJ; Park Y; Gwack J; Jin Y; Song J; Seo S; Gill B; Kim H; Park Y; Yoo CK; Jeong EK
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696519
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 reinfection in a cancer patient with a defective neutralizing humoral response.
Borgogna C; De Andrea M; Griffante G; Lai A; Bergna A; Galli M; Zehender G; Castello L; Ravanini P; Cattrini C; Mennitto A; Gennari A; Gariglio M
J Med Virol; 2021 Dec; 93(12):6444-6446. PubMed ID: 34260066
[No Abstract] [Full Text] [Related]
16. Lack of innate interferon responses during SARS coronavirus infection in a vaccination and reinfection ferret model.
Cameron MJ; Kelvin AA; Leon AJ; Cameron CM; Ran L; Xu L; Chu YK; Danesh A; Fang Y; Li Q; Anderson A; Couch RC; Paquette SG; Fomukong NG; Kistner O; Lauchart M; Rowe T; Harrod KS; Jonsson CB; Kelvin DJ
PLoS One; 2012; 7(9):e45842. PubMed ID: 23029269
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 Reinfection in a Healthcare Worker Despite the Presence of Detectable Neutralizing Antibodies.
Brehm TT; Pfefferle S; von Possel R; Kobbe R; Nörz D; Schmiedel S; Grundhoff A; Olearo F; Emmerich P; Robitaille A; Günther T; Braun P; Andersen G; Knobloch JK; Addo MM; Lohse AW; Aepfelbacher M; Fischer N; Schulze Zur Wiesch J; Lütgehetmann M
Viruses; 2021 Apr; 13(4):. PubMed ID: 33921216
[TBL] [Abstract][Full Text] [Related]
18. Protection against reinfection with D614- or G614-SARS-CoV-2 isolates in golden Syrian hamster.
Brustolin M; Rodon J; Rodríguez de la Concepción ML; Ávila-Nieto C; Cantero G; Pérez M; Te N; Noguera-Julián M; Guallar V; Valencia A; Roca N; Izquierdo-Useros N; Blanco J; Clotet B; Bensaid A; Carrillo J; Vergara-Alert J; Segalés J
Emerg Microbes Infect; 2021 Dec; 10(1):797-809. PubMed ID: 33825619
[TBL] [Abstract][Full Text] [Related]
19. Immune response variables and viral mutations impact on COVID-19 reinfection and relapse.
Sanaie S; Golipour E; Shamekh A; Sadaie MR; Mahmoodpoor A; Yousefi M
Int Immunopharmacol; 2021 Nov; 100():108108. PubMed ID: 34521025
[TBL] [Abstract][Full Text] [Related]
20. Neutralizing antibody responses to SARS-CoV-2 in COVID-19 patients.
Deshpande GR; Sapkal GN; Tilekar BN; Yadav PD; Gurav Y; Gaikwad S; Kaushal H; Deshpande KS; Kaduskar O; Sarkale P; Baradkar S; Suryawanshi A; Lakra R; Sugunan AP; Balakrishnan A; Abraham P; Salve P
Indian J Med Res; 2020 Jul & Aug; 152(1 & 2):82-87. PubMed ID: 32859866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
